Modulation of lymphocyte responsiveness to phytohemagglutinin by micromolecular fibrinogen degradation products.
The ability of fibrinogen degradation products (FDP) to influence the regulatory function of adherent cells from peripheral blood mononuclear cells (PBMC) was evaluated. FDP were prepared by digestion of fibrin clots with plasmin. These FDP were incubated overnight with glass-adherent cells following which these treated and untreated cells were cocultivated with fresh autologous responder PBMC in the presence of the T-cell mitogen, phytohemagglutinin (PHA). Lipid metabolism of FDP-treated monocytes was evaluated in cells that had been prelabeled with [3H]arachidonic acid (AA) prior to their overnight incubation with FDP; supernatants were analyzed for conversion of AA to cyclooxygenase and lipoxygenase products by thin-layer chromatography. Treatment of glass-adherent cells with the FDP digests converted these monocytes into suppressor cells. The suppression exerted by these cells in the PHA assay was dose dependent. The suppression exerted by FDP-pretreated monocytes was reversed by treating the PHA-stimulated cocultures with indomethacin and was associated with increased cyclooxygenase activity. These studies demonstrated that FDP can alter T-cell immune function through the induction of monocyte suppressor cells; the means by which that occurs is associated with stimulation of lipid metabolism and secretion of eicosanoids with immunoregulatory capacity.
D001095:Arachidonic Acids / Q000378:metabolism; D004261:DNA Replication / Q000187:drug effects; D003864:Depression, Chemical; D005338:Fibrin Fibrinogen Degradation Products / Q000494:pharmacology*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D010835:Phytohemagglutinins / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects
D001095:Arachidonic Acids; D005338:Fibrin Fibrinogen Degradation Products; D010835:Phytohemagglutinins; D007213:Indomethacin